Cervicovaginal cytology in carcinosarcoma [malignant mixed mullerian (mesodermal) tumor] of the uterus
- 1 January 1992
- journal article
- research article
- Published by Wiley in Diagnostic Cytopathology
- Vol. 8 (1) , 33-40
- https://doi.org/10.1002/dc.2840080108
Abstract
We examined the cervicovaginal cytology (PAP) findings in a series of 21 endometrial and 2 cervical carcinosarcomas (CS) [malignant mixed mullerian (mesodermal) tumors] (MMMT). Initial cytology diagnosis was positive for cancer in 14 of 23 cases (sensitivity of 61%); however, CS was correctly identified only 2 times. The remaining 12 cancer diagnoses were carcinomas: 10 adenocarcinomas (4 endometrial, 1 cervical, and 5 adenocarcinomas not otherwise specified), 1 squamous carcinoma, and 1 poorly differentiated carcinoma. Seventeen smears were available for review, all 8 false negative, one unsatisfactory, and 8 of 14 true positive smears. One false negative smear showed rare clusters diagnostic of adenocarcinoma. The remaining 7 false negative smears showed 3 high grade squamous dysplasias (two with additional findings: one showed atypical spindle cells and the other showed endometrial stromal cells), 2 extensive repair changes, and 2 negatives. The unsatisfactory smear showed atypical spindle cells. Review of the 8 true positive smears confirmed malignant spindle cells in the two cases originally identified as CS by cytology and in 3 other cases originally identified as adenocarcinoma. Of 9 smears positive for cancer available for review, 4 showed only carcinoma cells. PAP positive for cancer was associated with high stage at presentation (P <.025) and recurrent disease (P <.001) (even among stage I or II patients, P <.025). PAP positive for cancer showed no association with depth of myometrial invasion, size, grade, or histologic type of carcinosarcoma. The results of this study demonstrate the importance of consultative cytology reporting in which recommendations for appropriate biopsy are included in the report. The sensitivity of PAP could be increased to 83% (19/23 of cytologic findings would have led to biopsy recommendations). With consultative reporting, we can communicate that a biopsy is needed to establish a definitive diagnosis in many cases. For this reason, the confusing and potentially clinically damaging discrepancy between cytology and histology is minimized.Keywords
This publication has 28 references indexed in Scilit:
- Prognostic Factors for Malignant Mixed Mullerian Tumors of the UterusInternational Journal of Gynecological Pathology, 1990
- The Significance of Epithelial Differences in Mixed Mesodermal Tumors of the UterusThe American Journal of Surgical Pathology, 1990
- Solid teratomas and mixed Müllerian tumors of the ovary: A clinical histological, and immunocytochemical comparative studyGynecologic Oncology, 1989
- Peritoneal cytology in malignant mixed müllerian tumors of the uterusGynecologic Oncology, 1989
- Clinicopathologic features of ovarian mixed mesodermal tumors and carcinosarcomasGynecologic Oncology, 1989
- Extrauterine Pelvic Malignant Mixed Mesodermal Tumors; A Study of 10 Cases with ImmunohistochemistryInternational Journal of Gynecological Pathology, 1988
- Extragenital malignant mixed müllerian tumorGynecologic Oncology, 1988
- Malignant mixed mullerian tumor arising in extragenital endometriosis: Report of a case and review of the literatureGynecologic Oncology, 1986
- Epithelial antigens in malignant mixed Müllerian tumours of endometriumThe Journal of Pathology, 1986
- Metaplasias and neoplasias of Müllerian epitheliumHistopathology, 1984